Meet the Fund Manager
Michael GoldbergManaging Director and Portfolio ManagerCollins St Asset Management
Friday, 5th November 12pm (AEDT)
This exclusive event gives investors unprecedented access to Australia’s leading fund managers to hear about their favourite companies, unique market insights, and the opportunity to ask questions.
This is an opportunity to hear from Samuel Berridge, Portfolio Manager and Resources Analyst at Perennial Partners.
Join Samuel to learn about:
- Perennial’s 3 favourite stocks
- Market insights and outlook
- Investment approach and strategy
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.
Perennial is a house of specialist investment teams renowned for its ‘client first’ approach and its strategic, operational and distribution expertise. The company has true skin in the game, creating a powerful alignment of interests, and positions its portfolios for long-term success with active management and independent research. Samuel Berridge, Portfolio Manager and Resources Analyst, has 15 years’ experience across the mining and finance industries. He specialises in mining, mining services, oil and gas, hard commodity and small industrial sectors. In 2011, Samuel’s stock selection skills won him StarMine’s top Australian Metals and Mining Analyst Award
Luke Winchester Founder and Portfolio Manager
Luke Winchester, Founder and Portfolio Manager at Merewether Capital, started the company with the intention of applying his vast microcap investment knowledge to a new top-performing fund. Luke has over 10 years’ experience in microcap investing, most recently serving as Emerging Companies Portfolio Manager at Oracle Investment Management.
Robert Calnon OC Funds Management
Hear about OC Funds Management, whose microcap fund was recently crowned Australia’s best-performing microcap fund by Morningstar (total return over five years). Robert Calnon, one of OC’s three highly experienced portfolio managers, shares his smallcap investing insights with us.
Matt McNamara Horizon 3 Biotech
Matt is a specialist in human healthcare technology and is passionate about investing in the commercialisation of this industry. He has spent more than 30 years in the healthcare and medical sciences sector and has more than 20 years’ experience as a venture capitalist. His business acumen and strong background in the life sciences sector make him one of the industry’s most credible investment voices.